Skip to main content
Home

Breadcrumb

  1. Coronavirus

Will treatment costs be reimbursed by health insurers?

Answer

The list of items covered by compulsory health insurance does not currently include any medicinal cannabis products. Although efficacy has been shown for certain finished medicinal products in specific indications (FOPH HTA report), the criteria required for listing (efficacy, appropriateness and cost-effectiveness), and thus reimbursement, have not yet been deemed to be met. For this reason, reimbursement under compulsory health insurance may only be possible if, inter alia, use of the medicinal product is an indispensable prerequisite for the provision of a different service which is covered by compulsory health insurance and is clearly the priority concern; or if use of the medicinal product is expected to provide a major therapeutic benefit in a condition which may be fatal or lead to severe and chronic health impairments for the person insured and, owing to a lack of therapeutic alternatives, no other effective and authorised treatment method is available (so-called reimbursement on an individual basis, Art. 71a ff. of the Health Insurance Ordinance of 27 June 1995 [KVV]). According to the HTA report, however, a major therapeutic benefit is not to be expected even with the finished medicinal products. Reimbursement on an individual basis always also requires prior confirmation from the health insurer. With appropriate coverage, however, reimbursement may have to be provided under supplementary insurance.

Related Questions

I’m pregnant and have questions about the coronavirus. Who should I contact?
I am infected with the coronavirus. Can I breastfeed my child?
I am pregnant and I’ve contracted the coronavirus. Is my baby at risk?
I’m pregnant and infected with the coronavirus and the baby is due. What should I do?
Can COVID-19 (coronavirus disease) be treated with antibiotics?
FAQ Software by 10+

Navigation

  • Krankenversicherung
  • Ambulant vor Stationär
  • Gesetzgebung Krebsregistrierung
  • CFQ
    • Strategie und Ziele
    • Finanzierung und Reglement
    • Formulaire de demande
    • Beurteilung der Gesuche
  • Cannabis
    • Cannabis for medical purposes
  • Coronavirus Gesundheitsfachpersonen
    • Allgemeine Informationen zu Covid-19
    • Impfstrategie und -empfehlungen
    • Covid-19-Impfung
    • Covid-Zertifikat (für Gesundheitsfachpersonen)
    • Unerwünschte Impferscheinungen
    • Krankheit und Symptome
    • Schutzmassnahmen
    • Umsetzung in der Praxis
    • Schwangere, Neugeborene und Migrationsbevölkerung
    • Sozialmedizinische Institutionen und Patientenverfügungen
    • Zielgruppen
    • Umgang mit Erkrankten
  • Coronavirus
    • Infection and risks
    • COVID certificate
    • Vaccination
    • Isolation and contact with a person who has tested positive
    • Children and school
    • Disease, symptoms, treatment
    • Masks
    • Travel
    • Pregnancy
    • SwissCovid app
    • Tests

Language:

  • English
  • Deutsch
  • Italian
  • Français
Home

Footer

  • made in ?? by zehnplus